| Bacillus anthracis |
Anthrax lethal factor |
Potency |
7943.3 |
nM |
None |
| Bos taurus |
Trypsin I |
Ki |
2000000.0 |
nM |
10.1016/S0960-894X(97)00210-2 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
631.0 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
63.1 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
63.1 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Dihydrofolate reductase |
Inhibition |
nan |
% |
10.1021/jm1010572 |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
1995262.3 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
6510.4 |
nM |
None |
| Homo sapiens |
HERG |
IC50 |
4365158.32 |
nM |
10.1016/j.ejmech.2010.11.042 |
| Homo sapiens |
HERG |
IC50 |
4400000.0 |
nM |
10.1016/j.bmcl.2004.06.070 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-20.52 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
3.71 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
22.4 |
nM |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
27876.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Plasminogen |
Ki |
2000000.0 |
nM |
10.1016/S0960-894X(97)00210-2 |
| Homo sapiens |
Prelamin-A/C |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 3 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
1.2 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
3.8 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombin |
Ki |
2000000.0 |
nM |
10.1016/S0960-894X(97)00210-2 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
125.9 |
nM |
None |
| Homo sapiens |
Transcriptional regulator ERG |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv1.1 |
IC50 |
89000.0 |
nM |
10.1021/acs.jmedchem.6b01262 |
| Homo sapiens |
Voltage-gated potassium channel subunit Kv1.3 |
Kd |
195000.0 |
nM |
10.1021/jm030523s |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
20000.0 |
nM |
10.1021/jm2001103 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC90 |
20.0 |
uM |
10.1021/jm2001103 |
| Leishmania major |
Dihydrofolate reductase |
Inhibition |
nan |
% |
10.1021/jm1010572 |
| Leishmania major |
Pteridine reductase 1 |
IC50 |
1900000.0 |
nM |
10.1021/jm1010572 |
| Mus musculus |
Choline transporter |
Ki |
480839.35 |
nM |
10.1016/j.bmcl.2010.06.090 |
| Mus musculus |
Mus musculus |
ED50 |
8.4 |
mg.kg-1 |
10.1021/jm901688m |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
500000.0 |
nM |
10.1021/jm990224w |
| Rattus norvegicus |
Acetylcholinesterase |
Relative potency |
0.0004 |
None |
10.1021/jm990224w |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
25099.9 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
Control |
94.0 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
96.2 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
96.3 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
96.5 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
96.7 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
97.3 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
99.9 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
102.4 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
104.0 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
105.0 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
105.5 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
107.6 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
112.2 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
112.7 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
116.8 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
118.0 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
128.1 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
131.5 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
131.6 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
170.9 |
% |
10.1016/S0960-894X(00)80544-2 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.005639 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.005778 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.006139 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.009333 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.01069 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.01286 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.01764 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Rattus norvegicus |
TIME |
0.02564 |
hr |
10.1016/j.bmcl.2007.10.077 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
89125.1 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
22.94 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
27.93 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1111 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-6.59 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.17 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.05 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.1168 |
None |
10.1101/2020.04.03.023846 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
756.9 |
nM |
None |
| Trypanosoma cruzi |
Cruzipain |
Potency |
3162.3 |
nM |
None |
| Trypanosoma cruzi |
Cruzipain |
Potency |
3548.1 |
nM |
None |
| None |
ADMET |
Activity |
105.3 |
% |
10.1021/acs.jmedchem.6b01262 |
| None |
ADMET |
Activity |
105.7 |
% |
10.1021/acs.jmedchem.6b01262 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/jm2001103 |
| None |
Molecular identity unknown |
Potency |
70794.6 |
nM |
None |
| None |
No relevant target |
Dissociation constant |
9.25 |
None |
10.1021/jm00178a008 |
| None |
No relevant target |
LogP |
0.26 |
None |
10.1021/jm00227a008 |
| None |
No relevant target |
LogP |
0.28 |
None |
10.1021/jm00227a008 |
| None |
No relevant target |
pKa |
9.13 |
None |
10.1021/jm2001103 |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.122 |
uM |
None |
| None |
Unchecked |
Ac50 |
17.78 |
uM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
AC50 |
1122.0 |
nM |
None |
| None |
Unchecked |
AC50 |
17782.8 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01262 |
| None |
Unchecked |
Activity |
nan |
None |
None |
| None |
Unchecked |
IC50 |
50000.0 |
nM |
None |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Kd |
29000.0 |
nM |
10.1021/jm030523s |
| None |
Unchecked |
Kd |
270000.0 |
nM |
10.1021/jm030523s |
| None |
Unchecked |
Kd |
290000.0 |
nM |
10.1021/jm030523s |
| None |
Unchecked |
Kd |
590000.0 |
nM |
10.1021/jm030523s |
| None |
Unchecked |
Kd |
nan |
nM |
10.1021/jm030523s |
| None |
Unchecked |
Potency |
6309.6 |
nM |
None |
| None |
Unchecked |
Potency |
25118.9 |
nM |
None |
| None |
Unchecked |
Potency |
39810.7 |
nM |
None |
| None |
Unchecked |
Ratio CC50/EC50 |
10.0 |
None |
10.1021/jm2001103 |